None of the 13 search results mention "SPBC106.12c Antibody" in any context. The indexed studies focus on monoclonal antibodies against targets such as:
These antibodies are extensively characterized in terms of structure, efficacy, and clinical applications, but no data align with the identifier "SPBC106.12c."
The identifier "SPBC106.12c" does not conform to standard antibody naming conventions (e.g., IgG1, IgA, or commercial codes like HL6).
It may represent an internal code from a proprietary study, a typographical error, or a hypothetical compound not yet published.
The search results span peer-reviewed articles up to March 2025, yet none reference this antibody.
Antibodies are typically cataloged in public databases (e.g., UniProt, PubMed, ClinicalTrials.gov) once characterized. A lack of entries suggests it has not been formally studied or reported.
To resolve this ambiguity, consider:
Verifying the Identifier: Confirm the accuracy of "SPBC106.12c" and cross-reference with:
UniProt Knowledgebase (antibody sequences)
ClinicalTrials.gov (ongoing studies)
Patent Databases (proprietary antibodies)
Consulting Primary Sources: Contact institutions or researchers specializing in antibody development for unpublished data.
Revisiting Recent Literature: Periodically check updates in journals like Nature Biotechnology or mAbs for emerging studies.
SPBC106.12c is a gene identifier in Schizosaccharomyces pombe that appears to be related to cell wall integrity and polysaccharide metabolism. Based on homology studies, proteins encoded by this locus may share functional similarities with Sup11p, which has been identified as essential for β-1,6-glucan formation in the fission yeast cell wall . The significance lies in understanding fundamental cell wall biosynthesis pathways, as these processes are critical for cell viability and morphogenesis in fungi. Research using antibodies against SPBC106.12c provides insights into protein localization, function, and regulatory mechanisms that control cell wall integrity.
Antibodies against SPBC106.12c are typically generated using recombinant protein expression systems. The process involves:
Cloning the SPBC106.12c gene or specific regions into expression vectors
Expressing the protein in bacterial (E. coli) or eukaryotic systems
Purifying the recombinant protein using affinity tags
Immunizing animals (rabbits or mice) with the purified protein
Collecting and purifying the resulting antibodies
Similar to approaches used for other research antibodies, GST-fusion peptides can be used for antigen purification, followed by affinity purification of polyclonal antibodies as described in methodological studies with S. pombe proteins .
For immunofluorescence studies with SPBC106.12c antibodies in S. pombe, methanol fixation has proven effective. The recommended procedure includes:
Harvest cells during logarithmic growth phase
Fix cells in cold methanol (-20°C) for 8-10 minutes
Wash 3 times with phosphate-buffered saline (PBS)
Block with PBS containing 1% bovine serum albumin (BSA) for 30 minutes
Incubate with primary antibody (anti-SPBC106.12c) at appropriate dilution (typically 1:100 to 1:500)
Wash and apply fluorescently-labeled secondary antibody
This method preserves subcellular structures while allowing antibody access to intracellular epitopes, as has been successfully employed in S. pombe immunofluorescence labeling protocols .
To investigate interactions between SPBC106.12c and cell wall synthesis components, multiple complementary approaches should be considered:
Genetic interaction studies: Create conditional mutants of SPBC106.12c (using systems like nmt81 promoter) and cross with strains carrying mutations in known cell wall synthesis genes. Analyze synthetic lethality or suppressor effects, similar to approaches used to demonstrate genetic interactions between sup11+ and β-1,6-glucanase family members .
Co-immunoprecipitation: Use SPBC106.12c antibodies to pull down protein complexes, followed by mass spectrometry to identify interacting partners.
Subcellular localization studies: Perform double-labeling immunofluorescence with antibodies against SPBC106.12c and known cell wall synthesis proteins.
Cell wall composition analysis: Compare β-glucan partitioning in wild-type versus SPBC106.12c-depleted cells using aniline blue staining, as was performed for Sup11p studies .
A combination of these approaches will provide stronger evidence for functional associations between SPBC106.12c and the cell wall synthesis machinery.
Ensuring antibody specificity is critical for reliable research outcomes. For SPBC106.12c antibodies, validation should include:
Western blot analysis with appropriate controls:
Wild-type S. pombe extracts
SPBC106.12c deletion strain (if viable) or conditional mutant extracts
Preabsorption of antibody with purified antigen
Cross-reactivity assessment:
Test against related proteins in S. pombe
Evaluate specificity in other yeast species (e.g., S. cerevisiae)
Immunoprecipitation followed by mass spectrometry:
Confirm that the main protein pulled down is indeed SPBC106.12c
Identify any cross-reactive proteins
Comparison of different antibody preparations:
Polyclonal versus monoclonal antibodies
Antibodies raised against different regions of the protein
Validation approaches similar to those used for purification of polyclonal antibodies raised against GST-fusion peptides should be employed to ensure specificity .
Transcriptomic analysis can provide valuable insights into SPBC106.12c function:
Differential expression analysis after SPBC106.12c depletion or overexpression:
Identify genes with altered expression
Group affected genes into functional categories
Compare with existing transcriptome datasets
Co-expression network analysis:
Identify genes with similar expression patterns
Construct functional networks based on co-expression data
Pathway enrichment analysis:
Look for enriched biological processes
Identify cellular components affected
For example, studies with related S. pombe proteins revealed that depletion affected oligosaccharide catabolic processes, cell wall proteins, and the septum separation pathway at the transcriptional level, with 439 up-regulated and 239 down-regulated genes identified in restrictive conditions .
For subcellular fractionation of S. pombe to study SPBC106.12c localization:
Sucrose Density Gradient Centrifugation Protocol:
Cell preparation:
Grow S. pombe cells to mid-log phase
Convert to spheroplasts using zymolyase (1.5 mg/ml in 1.2M sorbitol)
Gently lyse spheroplasts using Dounce homogenizer
Gradient preparation:
Prepare 10-60% sucrose gradients in appropriate buffer
Layer cell lysate on gradient
Centrifuge at 100,000 × g for 3 hours at 4°C
Fraction collection and analysis:
Collect 1 ml fractions from top to bottom
Analyze fractions by Western blot using SPBC106.12c antibody
Use organelle markers to identify fractions (e.g., BiP for ER, Pma1p for plasma membrane)
Data presentation:
Plot protein distribution across fractions
Compare with distribution of known marker proteins
This method has been successfully employed for cellular fractionation of S. pombe proteins in previous studies .
Immunogold electron microscopy provides high-resolution localization data. For SPBC106.12c:
Sample preparation:
Fix S. pombe cells with 0.1% glutaraldehyde/2% paraformaldehyde
Embed in LR White or Lowicryl resin
Prepare ultrathin sections (70-90 nm)
Immunolabeling:
Block sections with 1% BSA/0.1% Tween-20 in PBS
Incubate with SPBC106.12c antibody (1:50 to 1:200 dilution)
Apply gold-conjugated secondary antibody (5nm or 10nm gold particles)
Enhance contrast with uranyl acetate and lead citrate
Optimization parameters:
Test different fixation conditions
Vary antibody concentrations
Compare different embedding media
Evaluate various antigen retrieval methods
Controls:
Omission of primary antibody
Use of pre-immune serum
Labeling of SPBC106.12c-depleted cells
This approach aligns with methods successfully used for immunogold electron microscopy in S. pombe studies .
Proteinase K protection assays help determine protein orientation in membranes:
Detailed Protocol:
Membrane isolation:
Prepare spheroplasts from S. pombe cells
Lyse spheroplasts by gentle homogenization
Isolate membrane fraction by differential centrifugation
Proteinase K treatment:
Divide membrane fractions into multiple tubes
Add proteinase K (50-100 μg/ml) to samples
Include samples with and without detergent (1% Triton X-100)
Incubate at 30°C for various times (0, 15, 30 minutes)
Reaction termination and analysis:
Stop reactions with 5mM PMSF
Process samples for SDS-PAGE
Perform Western blot with antibodies against different domains of SPBC106.12c
Include controls for known membrane proteins
Data interpretation:
Protein domains exposed to cytosol will be digested in intact membranes
Lumenal domains will be protected unless detergent is added
Compare digestion patterns with proteins of known topology
This methodology has been successfully applied to determine membrane protein topology in S. pombe .
Common challenges and solutions when using SPBC106.12c antibodies in Western blotting:
| Challenge | Possible Causes | Solutions |
|---|---|---|
| Weak signal | Low antibody concentration | Increase antibody concentration; Use signal enhancement systems |
| Low protein expression | Load more protein; Enrich membrane fractions | |
| Inefficient transfer | Optimize transfer conditions for membrane proteins | |
| Multiple bands | Cross-reactivity | Use more stringent blocking conditions |
| Post-translational modifications | Validate with glycosidase treatments (e.g., EndoH) | |
| Protein degradation | Add more protease inhibitors; Reduce sample processing time | |
| High background | Non-specific binding | Increase blocking agent concentration |
| Inadequate washing | Extend washing steps; Add mild detergents to wash buffer | |
| No signal | Protein denaturation affecting epitope | Try native protein extraction methods |
| Epitope masking | Try different extraction buffers |
For membrane proteins like those studied in S. pombe, EndoH treatment can help distinguish glycosylated forms and confirm protein identity .
When facing discrepancies between immunofluorescence and fractionation data:
Evaluate fixation artifacts:
Compare different fixation methods (paraformaldehyde vs. methanol)
Use live-cell imaging with GFP-tagged SPBC106.12c when possible
Consider dynamic localization:
Examine cells at different cell cycle stages
Test various growth conditions and stresses
Assess antibody access issues:
Try detergent permeabilization variations
Use antigen retrieval methods
Validate fractionation quality:
Confirm clear separation of organelle markers
Test for cross-contamination between fractions
Reconciliation approaches:
Perform immunoelectron microscopy as a tie-breaker
Use proximity labeling methods (BioID, APEX)
Employ super-resolution microscopy techniques
Similar challenges have been addressed in studies localizing S. pombe proteins, where multiple approaches including C- and N-terminal tagging with diverse fluorochromes, immunolabeling, and cellular fractionation were used to resolve localization discrepancies .
For rigorous analysis of SPBC106.12c function using conditional mutants:
Strain construction and validation:
Generate repressible promoter strains (e.g., using nmt81 promoter system)
Confirm protein depletion by Western blot
Determine viability in repressive conditions
Phenotypic characterization timeline:
Establish time course after gene repression
Document when specific phenotypes appear
Distinguish primary from secondary effects
Multi-parameter analysis:
Cell morphology (phase contrast microscopy)
Cell wall integrity (aniline blue staining)
Cell cycle progression (DAPI staining and FACS)
Protein secretion (reporter assays)
Genetic interaction studies:
Test interactions with cell wall synthesis genes
Look for suppressor or synthetic phenotypes
This approach aligns with successful strategies used for analyzing conditionally lethal mutants in S. pombe, such as the nmt81-sup11 knock-down mutant which revealed severe morphological defects and malformation of the septum with massive accumulation of cell wall material .
Emerging research directions for SPBC106.12c antibodies include:
Advanced imaging applications:
Super-resolution microscopy to precisely map protein distribution
Live-cell antibody-based imaging using cell-permeable nanobodies
Correlative light and electron microscopy for multi-scale localization
Functional proteomics:
Antibody-based proximity labeling to identify transient interactors
Antibody-mediated protein degradation to study acute loss-of-function
Conformational antibodies to detect active vs. inactive protein states
Systems biology integration:
Combining antibody-based data with transcriptomics and metabolomics
Network analysis to position SPBC106.12c within cellular pathways
Computational modeling of cell wall biosynthesis incorporating SPBC106.12c function
Comparative studies across fungal species:
Cross-reactivity studies with homologous proteins in pathogenic fungi
Evolutionary conservation of protein function and localization
Potential as a model for understanding fungal cell wall formation